Stocktoria
Grifols, S.A. GRF.MC
ES · Bolsa de Madrid · XMAD · stock · Healthcare · website
Grifols, S.A. financials (annual, from 10-K)
Bars are annual figures from 2022 to 2025; red bars are negative (a loss or cash outflow).
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue | $7.5B | $7.2B | $6.6B | $6.1B |
| Gross profit | $2.9B | $2.8B | $2.5B | $2.2B |
| R&D expense | $426.0M | $384.0M | $395.0M | $361.1M |
| SG&A expense | $1.1B | $1.1B | $1.3B | $1.1B |
| Operating income | $1.3B | $1.2B | $718.0M | $679.0M |
| Interest expense | $576.0M | $602.0M | $516.0M | $444.5M |
| Income tax | $115.0M | $231.0M | $43.0M | $90.1M |
| Net income | $402.0M | $157.0M | $42.0M | $185.0M |
| EPS (diluted) | $0.59 | $0.23 | $0.09 | $0.31 |
| Operating cash flow | $1.0B | $902.0M | $217.0M | -$1.4M |
| Free cash flow | $624.0M | $530.0M | -$93.0M | -$394.3M |
| Cash & equivalents | $801.0M | $980.0M | $529.6M | $549.2M |
| Inventory | $3.3B | $3.6B | $3.5B | $3.2B |
| Total assets | $19.7B | $21.4B | $21.0B | $21.2B |
| Total liabilities | $12.1B | $12.8B | $13.5B | $13.3B |
| Shareholders' equity | $5.3B | $5.9B | $5.4B | $5.6B |
Growth · year-over-year · Revenue CAGR 7.5%
| Metric | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|
| Revenue growth | +4.3% | +9.4% | +8.7% | — |
| Net income growth | +156.1% | +273.8% | -77.3% | — |
| EPS growth | +156.5% | +155.6% | -71.0% | — |
| Free cash flow growth | +17.7% | — | — | — |
Each column is the change versus the prior fiscal year. Growth off a negative or zero base is shown as “—”. CAGR is the compound annual revenue growth across the years shown.
Source: company filings via Yahoo Finance · ES · as of 2025-12-31. Figures in EUR; non-US fundamentals are aggregated by Yahoo (shorter history); facts plus Stocktoria's own computed scores — not investment advice.